Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • iSpecimen's Cash & Equivalents rose 5884.65% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 5884.65%. This contributed to the annual value of $1.9 million for FY2024, which is 1985.17% down from last year.
  • Latest data reveals that iSpecimen reported Cash & Equivalents of $2.8 million as of Q3 2025, which was up 5884.65% from $588775.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Cash & Equivalents registered a high of $27.7 million during Q4 2021, and its lowest value of $588775.0 during Q2 2025.
  • In the last 5 years, iSpecimen's Cash & Equivalents had a median value of $2.8 million in 2023 and averaged $8.9 million.
  • As far as peak fluctuations go, iSpecimen's Cash & Equivalents surged by 388600.66% in 2021, and later tumbled by 9153.9% in 2023.
  • iSpecimen's Cash & Equivalents (Quarter) stood at $27.7 million in 2021, then plummeted by 44.81% to $15.3 million in 2022, then tumbled by 84.69% to $2.3 million in 2023, then fell by 19.85% to $1.9 million in 2024, then surged by 48.14% to $2.8 million in 2025.
  • Its Cash & Equivalents was $2.8 million in Q3 2025, compared to $588775.0 in Q2 2025 and $782563.0 in Q1 2025.